| 产品名称: | HEC-1-B |
|---|---|
| 商品货号: | TS212036 |
| Organism: | Homo sapiens, human |
| Tissue: | uterus; endometrium |
| Product Format: | frozen |
| Morphology: | epithelial |
| Culture Properties: | adherent |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease: | adenocarcinoma |
| Age: | 71 years |
| Gender: | female |
| Applications: | This cell line is a suitable transfection host. |
| Karyotype: | diploid to tetraploid with large submetacentric marker |
| Derivation: | This is a substrain of HEC-1-A (see ATCC HTB-112) isolated in 1968 by H. Kuramoto. |
| Clinical Data: | female |
| Antigen Expression: | Blood Type B; Rh+ |
| Tumorigenic: | Yes |
| Effects: | Yes, in nude mice (The cells form moderately well differentiated adenocarcinomas consistent with endometrial carcinoma (grade II).) Yes, in steroid-treated hamsters |
| Comments: | This is a substrain of HEC-1-A. Unlike HEC-1-A, this substrain exhibited a stationary growth period between the 135th and 190th days in culture and appeared on recovery to be flattened and more pavement patterned than the parent line.The predominant complement of chromosomes was double that observed for the parent line. |
| Complete Growth Medium: | The base medium for this cell line is ATCC-formulated Eagles Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing: |
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 mL of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37°C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:6 is recommended |
| Cryopreservation: | Culture medium, 95%; DMSO, 5% |
| Culture Conditions: | Temperature: 37°C |
| STR Profile: | Amelogenin: X CSF1PO: 10,12 D13S317: 11,16 D16S539: 11,12 D5S818: 11,13 D7S820: 9,11 THO1: 6,7 TPOX: 8,11 vWA: 18 |
| Isoenzymes: | AK-1, 1 ES-D, 1 G6PD, B GLO-I, 2 Me-2, 2 PGM1, 1 PGM3, 1-2 |
| Name of Depositor: | H Kuramoto |
| Deposited As: | Homo sapiens |
| References: | Kuramoto H. Studies of the growth and cytogenetic properties of human endometrial adenocarcinoma in culture and its development into an established line. Acta Obstet. Gynaecol. Jpn. 19: 47-58, 1972. PubMed: 4678779 Fogh J, et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58: 209-214, 1977. PubMed: 833871 Goodfellow M, et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59: 221-226, 1977. PubMed: 77210034 Presta M, et al. Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor beta. Cancer Res. 48: 6384-6389, 1988. PubMed: 3263185 Kuramoto H, et al. Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am. J. Obstet. Gynecol. 114: 1012-1019, 1972. PubMed: 4673779 St. Geme JW, et al. Characterization of the genetic locus encoding Haemophilus influenzae type b surface fibrils. J. Bacteriol. 178: 6281-6287, 1996. PubMed: 8892830 Schramm N, et al. Vesicles containing Chlamydia trachomatis serovar L2 remain above pH 6 within HEC-1B cells. Infect. Immun. 64: 1208-1214, 1996. PubMed: 8606080 The cells form moderately well differentiated adenocarcinomas consistent with endometrial carcinoma (grade II). |
| Cross References: | Nucleotide (GenBank) : AF004337 Homo sapiens 7S ribosomal RNA, mitochondrial gene, partial sequence. |